China NT Pharma Group Company Limited (HKG:1011)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4300
-0.0300 (-6.52%)
Jun 22, 2026, 2:39 PM HKT
Market Cap436.54M +56.0%
Revenue (ttm)26.88M -36.4%
Net Income-28.98M
EPS-0.05
Shares Out 949.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume85,000
Open0.4550
Previous Close0.4600
Day's Range0.4300 - 0.4550
52-Week Range0.4000 - 1.3500
Beta-2.00
AnalystsStrong Buy
Price Target22.60 (+5,155.81%)
Earnings DateAug 28, 2026

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers. It also provides healthcare related research and promotion services in relation to bone health k... [Read more]

Sector Healthcare
Founded 1995
Employees 22
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1011
Full Company Profile

Financial Performance

In 2025, HKG:1011's revenue was 24.16 million, a decrease of -36.36% compared to the previous year's 37.96 million. Losses were -26.04 million, -51.19% less than in 2024.

Financial numbers in CNY Financial Statements